Advocacy Comments on Medicare Program

On March 7, 2022, The Office of Advocacy of the U.S. Small Business Administration submitted the following comments on the U.S. Department of Health and Human Services’ Centers for Medicare and Medicaid Service’s proposed rule to revise the Medicare Advantage (Part C) program, and the Medicare Prescription Drug Benefit (Part D) program.

Comment Letter

Fact Sheet

Comments are closed.